Immediate Impact
3 from Science/Nature 55 standout
Citing Papers
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
2023 Standout
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions
2023 Standout
Works of G. Klouvas being referenced
XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis
2012
Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer
1994
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| G. Klouvas | 715 | 337 | 243 | 42 | 1.1k | |
| Sarah Duff | 445 | 173 | 521 | 37 | 1.3k | |
| P.N. Plowman | 250 | 251 | 144 | 55 | 1.0k | |
| Juliana Di Iulio | 619 | 211 | 307 | 33 | 1.0k | |
| Fang Li | 367 | 178 | 149 | 54 | 959 | |
| Anna Butturini | 294 | 98 | 256 | 48 | 1.1k | |
| Mary L. Ostrowski | 315 | 351 | 103 | 46 | 1.3k | |
| Francesco Spina | 425 | 93 | 169 | 53 | 1.2k | |
| G. Pagnucco | 475 | 151 | 175 | 68 | 1.4k | |
| Wei Luo | 304 | 329 | 176 | 38 | 1.1k | |
| Johannes Bras | 302 | 379 | 333 | 36 | 956 |
All Works
Loading papers...